SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech - Quaterly Results

18 Jan 2026 Evaluate
The Revenue for the quarter ended  December 2025 of Rs. 4506.58 millions grew by 22.37 % from Rs. 3682.78 millions.A slender decline of -0.02% was recorded to Rs. 306.26  millions from Rs. 306.31 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 515.22 millions from 509.66 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 4506.58 3682.78 22.37 12359.28 10049.75 22.98 14316.28 12029.10 19.01
Other Income 11.41 10.06 13.42 42.80 33.46 27.91 57.42 67.71 -15.20
PBIDT 515.22 509.66 1.09 1490.17 1373.81 8.47 1919.77 1680.25 14.26
Interest 39.53 22.78 73.53 95.39 65.09 46.55 95.84 97.02 -1.22
PBDT 475.69 486.88 -2.30 1394.78 1308.72 6.58 1823.93 1583.23 15.20
Depreciation 74.69 74.26 0.58 219.62 200.27 9.66 276.90 241.89 14.47
PBT 401.00 412.62 -2.82 1175.16 1108.45 6.02 1547.03 1341.34 15.33
TAX 94.74 106.31 -10.88 294.08 284.67 3.31 399.61 344.89 15.87
Deferred Tax -10.46 -8.43 24.08 -19.89 -13.68 45.39 -22.25 -16.70 33.23
PAT 306.26 306.31 -0.02 881.08 823.78 6.96 1147.42 996.45 15.15
Equity 110.76 110.71 0.05 110.76 110.71 0.05 110.73 110.49 0.22
PBIDTM(%) 11.43 13.84 -17.39 12.06 13.67 -11.80 13.41 13.97 -4.00

Rossari Biotech Share Price

478.75 10.95 (2.34%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3640.10
Tata Chemicals 809.45
SRF 2519.20
Pidilite Inds. 1375.55
Deepak Nitrite 1736.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×